Divi’s Laboratories Ltd, which has captured investor attention for some time now, has delivered healthy December quarter (Q3FY22) results. The company is into the custom synthesis (CS) business and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback